Kathia Cristina Abdalla

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial

Álvaro Romera, Sergiy Peredpaya, Yaroslav Shparyk et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 61 citations

Medicine, Oncology, Pharmacotherapy +8

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

Jaffer A. Ajani, Mikhail Abramov, Igor Bondarenko et al. · Annals of Oncology · 2017 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial

Arinilda Campos Bragagnoli, Raphael L. C. Araújo, Maurício Wagner Souto Ferraz et al. · British Journal of Cancer · 2021 · 38 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Association between thyroid nodule size and malignancy rate

Marcel Jinih, Farzana A. Faisal, Kathia Cristina Abdalla et al. · Annals of The Royal College of Surgeons of England · 2019 · 29 citations · Full text

Medicine, Oncology, Pathology +17

Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

Sun Young Rha, Lucjan Wyrwicz, Nina Karaseva et al. · Journal of Clinical Oncology · 2025 · 29 citations

Medicine, Oncology, Perioperative Medicine +17